Literature DB >> 9362333

Apical ANG II-stimulated PLA2 activity and Na+ flux: a potential role for Ca2+-independent PLA2.

B N Becker1, H F Cheng, R C Harris.   

Abstract

Type 1 angiotensin II (ANG II) receptors (AT1R), which mediate proximal tubule (PT) salt and water reabsorption, undergo endocytosis and recycling. Prior studies in a PT-like model (LLC-PKcl4 cells expressing rabbit AT1R) (LLC-PK-AT1R cells) determined that quinacrine, a nonspecific phospholipase A2 (PLA2) inhibitor, and the haloenol lactone suicide substrate (HELSS), a Ca2+-independent PLA2 inhibitor, attenuated apical (AP) AT1R recycling. Further studies were undertaken to examine the association between AT1R endocytotic movement and PLA2 activity in this model. AP ANG II (100 nM) increased [3H]arachidonic acid ([3H]AA) release 4.4 +/- 0.38-fold in LLC-PK-AT1R cells cultured on permeable supports. Basolateral (BL) ANG II had no significant effect. Reversed-phase high-performance liquid chromatography confirmed that AP ANG II stimulated free [3H]AA release. Quinacrine, HELSS, and palmitoyl trifluoromethyl ketone, another Ca2+-independent PLA2 inhibitor, inhibited AP ANG II-stimulated [3H]AA release, as did inhibiting AP AT1R internalization with phenylarsine oxide. The role of HELSS-inhibitable AA release in ANG II-mediated 22Na flux was examined, given the effects of AT1R-mediated PLA2 activity on salt and water reabsorption. AP ANG II (100 nM) stimulated 22Na flux (AP--> BL), a response inhibited by HELSS. Thus, in this model, AP AT1R activated PLA2 with concomitant 22Na flux (AP --> BL), suggesting a link between AP AT1R endocytotic movement, AT1R-stimulated PLA2 activity, and 22Na flux in this model. The effects of HELSS suggest that Ca2+-independent PLA2 activity may be involved in this AP ANG II response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362333     DOI: 10.1152/ajprenal.1997.273.4.F554

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Review: Intrarenal angiotensin II levels in normal and hypertensive states.

Authors:  L Gabriel Navar; Kenneth D Mitchell; Lisa M Harrison-Bernard; Hiroyuki Kobori; Akira Nishiyama
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2001-03       Impact factor: 1.636

Review 2.  Regulation of intrarenal angiotensin II in hypertension.

Authors:  L Gabriel Navar; Lisa M Harrison-Bernard; Akira Nishiyama; Hiroyuki Kobori
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

Review 3.  New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  Peptides       Date:  2011-06-14       Impact factor: 3.750

Review 4.  Intrarenal angiotensin II and hypertension.

Authors:  L Gabriel Navar; Hiroyuki Kobori; Minolfa Prieto-Carrasquero
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

Review 5.  New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents.

Authors:  Katerina Gurova
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

6.  Roles of ERK and cPLA2 in the angiotensin II-mediated biphasic regulation of Na+-HCO3(-) transport.

Authors:  Yuehong Li; Hideomi Yamada; Yoshihiro Kita; Motoei Kunimi; Shoko Horita; Masashi Suzuki; Yoko Endo; Takao Shimizu; George Seki; Toshiro Fujita
Journal:  J Am Soc Nephrol       Date:  2007-12-19       Impact factor: 10.121

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.